Free Newsletter
Report: Pfizer would pay $75M in Trovan case
Free newsletter via e-mail
Tools
Pfizer has agreed to pay $75 million to settle the long-running Nigerian case over a meningitis drug trial, African news sources report. The trial participants and families who sued will share the settlement with the Kano State Government in Nigeria. It's unclear at press time, however, whether all sides have approved the settlement deal. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: